February 8, 2025 Week in Review: Trade Wars, Earnings, and Labor Data
February 4, 2025 AI Ventures Soar as Trade Tensions Heat Up – Key Weekly Highlights
Nvidia Stock: Evaluating Competitive Risks Amid Growth Prospects
Apple: Valuation Concerns Persist Amid Fundamental Strength
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
Centene (CNC) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: February 14, 2025 (16:56)
Sector: HealthcareThe share price of Centene Corp. (CNC) now
Analysts predictions
Full report
This Week
|
Neutral | Opinions: Na |
Previous Week
|
Neutral | Opinions: Na |
Two Weeks Ago
|
Neutral | Opinions: Na |
Three Weeks Ago
|
Neutral | Opinions: Na |
Are you interested in Centene Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Centene stock price in 2025, 2026, 2027. How much will one Centene share be worth in 2025 - 2027?
When should I take profit in Centene stock? When should I record a loss on Centene stock? What are analysts' forecasts for Centene stock? What is the future of Centene stock? We forecast Centene stock performance using neural networks based on historical data on Centene stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Centene stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Centene shares. This happens once a day.
Historical and forecast chart of Centene stock
The chart below shows the historical price of Centene stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Centene stock price can be found in the table below.
Long-term forecasts by years.
Centene Corp. Analysts predictions review

Centene Corporation (CNC) shows a bullish outlook driven by strong revenue growth from Medicare and Medicaid programs, enhancing its resilience amid economic and regulatory uncertainties. Operational efficiencies, cost-management efforts, and diversified offerings, including specialty services and PBM, support margin expansion. Despite near-term challenges such as value-based care cost pressures and macroeconomic headwinds, CNC maintains an attractive valuation, trading at a discount to peers. Management's strategic focus on divesting non-core assets and improving financial efficiency positions the company for medium to long-term profitability and growth. These factors collectively signal a favorable environment for capital appreciation.

Centene Corporation: Balanced Growth Potential and Value Opportunity for Strategic Investors

Centene Corporation (CNC) demonstrates a compelling value proposition driven by its robust revenue growth, underpinned by strong demand within the managed care sector and expanding government-sponsored healthcare programs such as Medicare and Medicaid. This solid revenue foundation positions the company to weather economic variability while capturing share in an increasing healthcare market.
Key Drivers of Centene's Investment Appeal
The company's profitability metrics have strengthened as it continues executing operational efficiencies and cost-management initiatives. These efforts are expected to bolster margins, particularly as scale advantages in key Medicaid markets come to fruition, which will likely translate into enhanced earnings stability over the near term.
Strategic diversification of its healthcare offerings, including specialty services and pharmacy benefits management (PBM), adds a further layer of growth potential. By diversifying revenue streams, Centene mitigates exposure risk from potential regulatory changes, a critical consideration for investors in the healthcare space.
Valuation remains a focal point, with CNC currently trading at a discount to industry peers on a forward P/E basis. This undervaluation may reflect market skepticism regarding government-reimbursement complexities, but it simultaneously presents an opportunity for long-term investors seeking capital appreciation alongside potential dividend growth.

Centene Corporation: Strong Potential for a Q3 2024 Recovery Amid Strategic Tailwinds

Centene's focus on leveraging its Medicare and Medicaid advantage remains a critical growth driver. The company's strong market presence and ability to secure state contracts provide stability in revenues, while its efforts to expand into under-penetrated regions offer tangible long-term potential. However, challenges with managing costs in value-based care agreements could pressure margins in the near term.
The author emphasizes Centene's strategic initiatives to streamline operations and divest non-core assets, which could unlock shareholder value. These measures reduce complexity while improving cash flow and operational efficiency, setting the stage for enhanced financial performance heading into 2024.
Macroeconomic and Sector-Specific Impacts
Macroeconomic factors, including inflationary pressures and shifts in healthcare spending, may weigh on Centene's ability to manage administrative costs. Yet, with a strong balance sheet and significant contract renewals, the company appears well-positioned to weather short-term headwinds and capitalize on an eventual sector recovery.
Finally, the author suggests Centene's valuation, based on current multiples, remains attractive relative to peer groups. The stock trades at a discount, presenting a potential buying opportunity for investors looking to position themselves ahead of anticipated improvements in profitability and growth for Q3 2024.

Centene Corporation: Navigating Financial Stability with Strategic Prudence

Centene Corporation's emphasis on disciplined financial management underpins its resilience in the managed care sector. By maintaining a strong balance sheet and cost efficiency, the company is well-positioned to weather macroeconomic uncertainties, ensuring stable cash flows and shareholder confidence. The author highlights this operational prudence as a core strength, which could limit downside risks to the stock in the near term, despite external pressures.
Operational Dynamics and Competitive Landscape
The company's diversified revenue streams through government-sponsored healthcare programs provide a stable income base and a hedge against cyclical volatility. This strategic breadth, as noted by the author, enhances Centene's competitive moats, albeit with some exposure to regulatory adjustments that may temper immediate growth prospects.
Moreover, its focus on streamlining operations and improving efficiency metrics signals management's commitment to long-term margin expansion. The author suggests this could incrementally support valuation multiples once macro headwinds ease, offering investors a potential medium-term payoff.
However, the ongoing industry-wide cost pressures and regulatory changes present latent challenges. While the author acknowledges these factors, managing them effectively through Centene's conservative financial practices could safeguard its operational continuity and investor trust.
Centene Corporation operates as a multinational healthcare company that provides programs and services to underinsured and uninsured individuals in the United States. Its Managed Care segment offers health insurance plans to individuals through government-subsidized programs including Medicaid, the government’s child health insurance program, long-term services and supports, foster families and Medicare-medicaid plans that cover dual-eligible individuals, and programs for the elderly, blind or disabled.
Centene daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Feb 16 | 56.68 | 55.88 | 57.40 | 2.72 |
Feb 17 | 56.72 | 56.11 | 57.02 | 1.64 |
Feb 18 | 55.58 | 55.20 | 56.15 | 1.73 |
Feb 19 | 54.84 | 54.39 | 55.48 | 2.00 |
Feb 20 | 54.70 | 54.05 | 55.20 | 2.13 |
Feb 21 | 54.60 | 54.25 | 54.95 | 1.29 |
Feb 22 | 54.69 | 54.00 | 54.92 | 1.70 |
Feb 23 | 54.19 | 53.35 | 54.72 | 2.58 |
Feb 24 | 54.44 | 53.62 | 54.89 | 2.38 |
Feb 25 | 53.43 | 52.94 | 54.05 | 2.10 |
Feb 26 | 52.89 | 52.13 | 53.66 | 2.92 |
Feb 27 | 52.80 | 52.30 | 53.61 | 2.50 |
Feb 28 | 53.42 | 53.10 | 53.93 | 1.55 |
Mar 01 | 54.25 | 53.94 | 55.04 | 2.03 |
Mar 02 | 55.06 | 54.78 | 55.81 | 1.87 |
Mar 03 | 54.92 | 54.33 | 55.59 | 2.30 |
Mar 04 | 54.73 | 54.31 | 54.95 | 1.17 |
Mar 05 | 54.27 | 53.74 | 55.10 | 2.52 |
Mar 06 | 53.19 | 52.56 | 53.92 | 2.59 |
Mar 07 | 53.01 | 52.79 | 53.69 | 1.71 |
Mar 08 | 52.55 | 52.14 | 52.97 | 1.59 |
Mar 09 | 52.23 | 51.70 | 52.81 | 2.14 |
Mar 10 | 52.69 | 51.86 | 53.08 | 2.36 |
Mar 11 | 52.46 | 52.20 | 52.93 | 1.41 |
Mar 12 | 52.10 | 51.45 | 52.66 | 2.35 |
Mar 13 | 52.84 | 52.58 | 53.14 | 1.07 |
Mar 14 | 52.99 | 52.22 | 53.44 | 2.33 |
Mar 15 | 52.98 | 52.59 | 53.44 | 1.61 |
Mar 16 | 52.85 | 52.04 | 53.25 | 2.32 |
Mar 17 | 52.17 | 51.84 | 52.49 | 1.25 |
Centene Daily Price Targets
Centene Stock Forecast 02-16-2025.
Forecast target price for 02-16-2025: $56.68.
Negative dynamics for Centene shares will prevail with possible volatility of 2.647%.
Pessimistic target level: 55.88
Optimistic target level: 57.40
Centene Stock Forecast 02-17-2025.
Forecast target price for 02-17-2025: $56.72.
Positive dynamics for Centene shares will prevail with possible volatility of 1.611%.
Pessimistic target level: 56.11
Optimistic target level: 57.02
Centene Stock Forecast 02-18-2025.
Forecast target price for 02-18-2025: $55.58.
Negative dynamics for Centene shares will prevail with possible volatility of 1.703%.
Pessimistic target level: 55.20
Optimistic target level: 56.15
Centene Stock Forecast 02-19-2025.
Forecast target price for 02-19-2025: $54.84.
Negative dynamics for Centene shares will prevail with possible volatility of 1.957%.
Pessimistic target level: 54.39
Optimistic target level: 55.48
Centene Stock Forecast 02-20-2025.
Forecast target price for 02-20-2025: $54.70.
Negative dynamics for Centene shares will prevail with possible volatility of 2.081%.
Pessimistic target level: 54.05
Optimistic target level: 55.20
Centene Stock Forecast 02-21-2025.
Forecast target price for 02-21-2025: $54.60.
Negative dynamics for Centene shares will prevail with possible volatility of 1.272%.
Pessimistic target level: 54.25
Optimistic target level: 54.95
CNC (CNC) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Mar. | 61.01 | 59.89 | 64.92 | 7.74 |
Apr. | 59.01 | 57.27 | 60.29 | 5.01 |
May. | 58.54 | 55.12 | 61.30 | 10.08 |
Jun. | 57.56 | 54.93 | 59.12 | 7.09 |
Jul. | 56.78 | 55.73 | 58.46 | 4.66 |
Aug. | 58.27 | 55.52 | 60.14 | 7.67 |
Sep. | 57.34 | 55.60 | 59.86 | 7.13 |
Oct. | 55.92 | 53.32 | 59.27 | 10.04 |
Nov. | 53.73 | 52.27 | 54.76 | 4.55 |
Dec. | 52.65 | 49.96 | 53.71 | 6.98 |
Centene forecast for this year
Centene Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $61.0147. Pessimistic: $59.89. Optimistic: $64.92
Centene Stock Prediction for Apr 2025
An downtrend is forecast for this month with an optimal target price of $59.0134. Pessimistic: $57.27. Optimistic: $60.29
Centene Stock Prediction for May 2025
An downtrend is forecast for this month with an optimal target price of $58.5413. Pessimistic: $55.12. Optimistic: $61.30
Centene Stock Prediction for Jun 2025
An downtrend is forecast for this month with an optimal target price of $57.5578. Pessimistic: $54.93. Optimistic: $59.12
Centene Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $56.775. Pessimistic: $55.73. Optimistic: $58.46
Centene Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $58.2739. Pessimistic: $55.52. Optimistic: $60.14
Centene Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $57.3415. Pessimistic: $55.60. Optimistic: $59.86
Centene Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $55.9194. Pessimistic: $53.32. Optimistic: $59.27
Centene Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $53.7274. Pessimistic: $52.27. Optimistic: $54.76
Centene Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $52.6528. Pessimistic: $49.96. Optimistic: $53.71
Centene (CNC) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 49.45 | 47.63 | 50.84 | 6.30 |
Feb | 47.12 | 44.55 | 49.49 | 9.98 |
Mar | 50.77 | 49.23 | 53.66 | 8.25 |
Apr | 49.43 | 47.89 | 50.78 | 5.69 |
May | 53.27 | 52.33 | 54.89 | 4.66 |
Jun | 56.68 | 53.37 | 59.85 | 10.83 |
Jul | 57.86 | 56.89 | 60.68 | 6.25 |
Aug | 62.25 | 60.16 | 63.75 | 5.63 |
Sep | 62.35 | 58.76 | 65.05 | 9.66 |
Oct | 60.41 | 58.19 | 63.12 | 7.81 |
Nov | 56.83 | 54.24 | 58.24 | 6.87 |
Dec | 57.15 | 55.23 | 58.80 | 6.07 |
Centene (CNC) Monthly Stock Prediction for 2027
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 55.23 | 52.93 | 56.42 | 6.19 |
Feb | 58.28 | 54.92 | 60.70 | 9.52 |
Mar | 61.36 | 59.39 | 62.68 | 5.25 |
Apr | 64.20 | 62.05 | 66.87 | 7.22 |
May | 66.62 | 62.46 | 68.43 | 8.72 |
Jun | 61.55 | 58.94 | 65.15 | 9.52 |
Jul | 61.01 | 59.65 | 63.31 | 5.78 |
Aug | 63.06 | 60.19 | 64.53 | 6.72 |
Sep | 60.84 | 57.58 | 63.42 | 9.21 |
Oct | 62.16 | 59.22 | 64.69 | 8.45 |
Nov | 65.69 | 62.06 | 67.95 | 8.66 |
Dec | 70.10 | 67.13 | 73.02 | 8.06 |
Centene information and performance
7700 FORSYTH BLVD., ST LOUIS, MO, US
Market capitalization of the Centene Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CNC shares in the company outstanding by the market price of one share.
EBITDA of Centene is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Centene Stock)
Should I Buy Centene Shares in 2025 year?
Does Centene pay dividends?
Which economic sector do Centene's shares belong to?
Which other securities belong to the same sector as Centene's shares?
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.